Conversion from Calcineurin Inhibitors to Everolimus Resulted in Decrease of Serum TGF-beta and Urinary NGAL in Renal Transplant Recipients.

dc.authorid0000-0002-0721-6213
dc.contributor.authorAlpay, N.
dc.contributor.authorOzkok, A.
dc.contributor.authorCaliskan, Y.
dc.contributor.authorAkagun, T.
dc.contributor.authorCinar, S.
dc.contributor.authorDeniz, G.
dc.contributor.authorSariyar, M.
dc.date.accessioned2025-05-10T19:28:51Z
dc.date.issued2013
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description13th American Transplant Congress (ATC) -- MAY 18-22, 2013 -- Seattle, WA
dc.description.abstract[No abstract available]
dc.identifier.endpage545
dc.identifier.issn1600-6135
dc.identifier.scopusqualityQ1
dc.identifier.startpage545
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7490
dc.identifier.volume13
dc.identifier.wosWOS:000318240301956
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley-Blackwell
dc.relation.ispartofAmerican Journal of Transplantation
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleConversion from Calcineurin Inhibitors to Everolimus Resulted in Decrease of Serum TGF-beta and Urinary NGAL in Renal Transplant Recipients.
dc.typeConference Object

Dosyalar